The Dow Jones Industrial Average and other major indexes fell Monday afternoon as investors sold holdings in this ...

Shares in British biopharmaceutical firm Mereo Biopharma ($MREO) saw a wipeout of over 90% on Monday after two of its ...

Investing.com -- Mereo BioPharma Group plc (NASDAQ:MREO) stock plunged 90.3% on Monday after the company announced that its Phase 3 clinical trials for setrusumab in Osteogenesis Imperfecta failed to ...

Cytokinetics is a late-stage biopharmaceutical company targeting muscle function. Its stock has gained almost 30% this year, ...

Recent Alzheimer's drug approvals have put the biopharma industry back in the spotlight. Bank of America names seven stocks to buy to ride the trend.

(RTTNews) - Risk runs high, but so does the upside. Biotech investing thrives on bold bets and breakthrough data. On October 30, 2025, a wave of clinical-stage and commercial biopharma stocks surged ...

Today, Dec. 16, 2025, Pfizer's shrinking COVID cash flows could mean little growth next year as M&A bets will take time to ...